| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000030673 |
| Receipt No. | R000034901 |
| Official scientific title of the study | The safety and efficacy of direct oral anticoagulants in patients with atrial fibrillation (AF) |
| Date of disclosure of the study information | 2018/01/04 |
| Last modified on | 2018/01/04 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | The safety and efficacy of direct oral anticoagulants in patients with atrial fibrillation (AF) | |
| Title of the study (Brief title) | The safety and efficacy of direct oral anticoagulants in patients with atrial fibrillation (AF)(iDOAC registry) | |
| Region |
|
|
| Condition | ||
| Condition | atrial fibrillation | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The aim of this study is to examine whether DOAC is safe and efficient similar to warfarin in patients with AF. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | We investigate the new events of stroke and/or systemic embolism by the type of anticoagulant and therapy (medicine vs non medicine) during follow-up period of 12M after informed cocent. |
| Key secondary outcomes | Death(cardiovascular death/non-cardiovascular death), stroke(ischemic/hemorrhagic/unclassified), systemic embolism, cardiovascular event(acute myocardial infarction/unstable angina), hemorrhagic event (intracranial bleeding except hemorrhagic stroke, gastrointestinal bleeding), adverse event, others |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | (1)Japanese patient with anticoagulant therapy for non valvular atrial fibliration
(2)Patient with 20 years old and older (3)Patient signed Informed consent |
|||
| Key exclusion criteria | (1)Patient recieved or will recieve catheter ablation during follow up.
(2)Patient recieved catheter ablation for atrial fibliration in the past 6 month. (3)In patient with cancer, not noticed of cancer at the time of informed consent. (4)Patient judged unsuitable for the study by prncipal investigator or subinvetigator |
|||
| Target sample size | 1000 | |||
| Research contact person | |
| Name of lead principal investigator | Kenzo Hirao |
| Organization | Tokyo Medical and Dental University |
| Division name | Heart Rhythm Center |
| Address | 1-5-45, Yushima, Bunkyo-ku, Tokyo |
| TEL | 03-5803-5231 |
| 0160.cvm@tmd.ac.jp | |
| Public contact | |
| Name of contact person | Shingo Maeda |
| Organization | Tokyo Medical and Dental University |
| Division name | Heart Rhythm Center |
| Address | 1-5-45, Yushima, Bunkyo-ku, Tokyo |
| TEL | 03-5803-5231 |
| Homepage URL | |
| smaecvm@tmd.ac.jp | |
| Sponsor | |
| Institute | Tokyo Medical and Dental University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | DAIICHI SANKYO COMPANY, LIMITED |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 青梅市立総合病院(東京都)、柏市立柏病院(千葉県)、亀田総合病院(千葉県)、災害医療センター(東京都)、さいたま赤十字病院(埼玉県)、新百合ヶ丘総合病院(神奈川県)、草加市立病院(埼玉県)、東京共済病院(東京都)、JA とりで総合医療センター(茨城県)、平塚共済病院(神奈川)、武蔵野赤十字病院(東京都)、横浜みなと赤十字病院(神奈川県)、横浜南共済病院(神奈川県)、山手メディカルセンター(東京都) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | . |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034901 |